Published in
Elsevier, The Lancet, 9948(384), p. 1109-1117, 2014
DOI: 10.1016/s0140-6736(14)60958-2
Links
Tools
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
Journal article published in 2014 by
Caroline Robert,
Antoni Ribas,
Jedd D. Wolchok,
F. Stephen Hodi,
Omid Hamid,
Richard Kefford 
,
Jeffrey S. Weber ,
Anthony M. Joshua,
Wen-Jen Hwu,
Tara C. Gangadhar,
Amita Patnaik,
Roxana Dronca,
Hassane Zarour,
Richard W. Joseph,
Peter Boasberg
and other authors.
,
Jeffrey S. Weber ,
Anthony M. Joshua,
Wen-Jen Hwu,
Tara C. Gangadhar,
Amita Patnaik,
Roxana Dronca,
Hassane Zarour,
Richard W. Joseph,
Peter Boasberg
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 